MedPath

MAYO CLINIC

MAYO CLINIC logo
🇺🇸United States
Ownership
Subsidiary
Established
1889-01-01
Employees
10K
Market Cap
-
Website
http://www.mayoclinic.org

Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?

Phase 4
Terminated
Conditions
Hypertension
Interventions
First Posted Date
2012-05-24
Last Posted Date
2014-05-19
Lead Sponsor
Mayo Clinic
Target Recruit Count
1
Registration Number
NCT01605370
Locations
🇺🇸

Mayo Clinic Arizona, Scottsdale, Arizona, United States

Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction

Phase 3
Completed
Conditions
Breast Cancer
BRCA2 Mutation
Breast Diseases
Pain, Postoperative
BRCA1 Mutation
Neoplasms
Interventions
First Posted Date
2012-05-04
Last Posted Date
2019-10-10
Lead Sponsor
Mayo Clinic
Target Recruit Count
131
Registration Number
NCT01591746
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures.

Not Applicable
Terminated
Conditions
Obstruction
Stricture
Cancer
Interventions
Device: Large plastic biliary stent
First Posted Date
2012-05-03
Last Posted Date
2017-10-17
Lead Sponsor
Mayo Clinic
Target Recruit Count
3
Registration Number
NCT01590394
Locations
🇺🇸

Mayo Clinic Rochester, Rochester, Minnesota, United States

Histology of Functional Density in Premenopausal Breast

Completed
Conditions
Breast Cancer
Dense Breasts
First Posted Date
2012-05-01
Last Posted Date
2016-05-20
Lead Sponsor
Mayo Clinic
Target Recruit Count
23
Registration Number
NCT01588834
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

The Role That Peroral Endoscopic Myotomy (POEM) Could Play in the Treatment of Achalasia

Not Applicable
Completed
Conditions
Achalasia
Interventions
Procedure: Peroral Endoscopic Myotomy a less invasive treatment for Achalasia
First Posted Date
2012-04-25
Last Posted Date
2016-10-31
Lead Sponsor
Mayo Clinic
Target Recruit Count
20
Registration Number
NCT01584635
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Cytosponge Protocol IRB 11-006429

Not Applicable
Terminated
Conditions
Eosinophilic Esophagitis
Interventions
Device: Cytosponge
First Posted Date
2012-04-25
Last Posted Date
2022-06-13
Lead Sponsor
Mayo Clinic
Target Recruit Count
86
Registration Number
NCT01585103
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung Disease

Completed
Conditions
Chronic Lung Disease
Self-efficacy
First Posted Date
2012-04-24
Last Posted Date
2013-04-04
Lead Sponsor
Mayo Clinic
Target Recruit Count
70
Registration Number
NCT01583595
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Molecular Regulation of Muscle Glucose Metabolism

Phase 1
Terminated
Conditions
Obesity
Type 2 Diabetes Mellitus
Interventions
Drug: U100 Humulin
Other: Exercise
First Posted Date
2012-04-20
Last Posted Date
2017-11-27
Lead Sponsor
Mayo Clinic
Target Recruit Count
48
Registration Number
NCT01581736
Locations
🇺🇸

Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Non-Invasive EndoPAT Increases Diagnostic Yield of CAD by Coronary Angiography

Completed
Conditions
Coronary Artery Disease
First Posted Date
2012-04-20
Last Posted Date
2014-06-25
Lead Sponsor
Mayo Clinic
Target Recruit Count
201
Registration Number
NCT01581671
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Assessment of Coronary Plaque Composition

Phase 1
Completed
Conditions
Endothelial Dysfunction
Coronary Atherosclerosis
Coronary Small Vessel Disease
Interventions
Device: LipiScan/LipiScan IVUS
First Posted Date
2012-04-20
Last Posted Date
2019-03-05
Lead Sponsor
Mayo Clinic
Target Recruit Count
39
Registration Number
NCT01581632
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath